Does GLATIRAMER Cause Disease recurrence? 75 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Disease recurrence have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.2% of all adverse event reports for GLATIRAMER.
75
Reports of Disease recurrence with GLATIRAMER
0.2%
of all GLATIRAMER reports
0
Deaths
11
Hospitalizations
How Dangerous Is Disease recurrence From GLATIRAMER?
Of the 75 reports, 11 (14.7%) required hospitalization.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which GLATIRAMER Alternatives Have Lower Disease recurrence Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE